These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17447137)

  • 61. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial.
    Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
    JAMA; 2002 Mar; 287(12):1531-40. PubMed ID: 11911755
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nitroprusside in decompensated heart failure: what should a clinician really know?
    Opasich C; Cioffi G; Gualco A
    Curr Heart Fail Rep; 2009 Sep; 6(3):182-90. PubMed ID: 19723460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers.
    Abraham WT; Cheng ML; Smoluk G;
    Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.
    Gong B; Wu Z; Li Z
    BMJ Open; 2016 Jan; 6(1):e008545. PubMed ID: 26739721
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
    Graham CA
    Emerg Med Australas; 2004 Feb; 16(1):47-54. PubMed ID: 15239755
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Congestive Heart Failure.
    Scott MC; Winters ME
    Emerg Med Clin North Am; 2015 Aug; 33(3):553-62. PubMed ID: 26226866
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vasodilator therapy of cardiac failure: (first of two parts).
    Cohn JN; Franciosa JA
    N Engl J Med; 1977 Jul; 297(1):27-31. PubMed ID: 405585
    [No Abstract]   [Full Text] [Related]  

  • 70. Intravenous vasodilator therapy in congestive heart failure.
    Moazemi K; Chana JS; Willard AM; Kocheril AG
    Drugs Aging; 2003; 20(7):485-508. PubMed ID: 12749747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Nesiritide, a novel treatment for heart failure].
    Francisco-Méndez G
    Rev Med Inst Mex Seguro Soc; 2007; 45(3):281-9. PubMed ID: 17692167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Use of vasodilator agents for treating acute cardiac insufficiency].
    Gratsianskiĭ NA; Karpov IuA; Ruda MIa
    Kardiologiia; 1980 Oct; 20(10):25-31. PubMed ID: 6777574
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.
    Marti C; Cole R; Kalogeropoulos A; Georgiopoulou V; Butler J
    Curr Heart Fail Rep; 2012 Mar; 9(1):1-7. PubMed ID: 21874282
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Drug treatment of heart insufficiency].
    Follath F
    Schweiz Med Wochenschr; 1988 Dec; 118(50):1886-91. PubMed ID: 3065935
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vasodilators for heart failure--useful or useless?
    Franciosa JA
    Cardiology; 1988; 75 Suppl 1():110-7. PubMed ID: 3069208
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic advances in heart failure.
    Meinertz T; Drexler H; Just H
    Cardiovasc Drugs Ther; 1988 Nov; 2(Suppl 1):413-418. PubMed ID: 27722847
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Role of nitroglycerin for injection in comparison with other vasodilators in the treatment of cardiac failure of ischemic origin].
    Francoual M
    Nouv Presse Med; 1979 Jan; 8(4):293-6. PubMed ID: 122024
    [No Abstract]   [Full Text] [Related]  

  • 79. [The extension of heart failure therapy with vasodilators].
    Assmann I
    Z Gesamte Inn Med; 1990 Jun; 45(12):352-6. PubMed ID: 2201132
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Brain natriuretic peptide (nesiritide) in the treatment of heart failure.
    Bettencourt P
    Cardiovasc Drug Rev; 2002; 20(1):27-36. PubMed ID: 12070532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.